Lexicon Pharmaceuticals
LXRX
#6008
Rank
S$1.46 B
Marketcap
S$3.30
Share price
11.35%
Change (1 day)
172.02%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$0.47 M-96.17%
2025S$12.43 M-38.43%
2024S$20.19 M111.04%
2023S$9.57 M315.88%
2022S$2.3 M-91.22%
2021S$26.2 M1.63%
2020S$25.78 M21.18%
2019S$21.27 M-6.95%
2018S$22.86 M-27.5%
2017S$31.53 M18.35%
2016S$26.64 M59.83%
2015S$16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
S$4.05 MS$56.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$9.83 MS$25.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$1.89 MS$30.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$0.14 MS$8.24 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.97 MS$11.76 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$14.89 MS$22.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/AS$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$4.43 MS$17.27 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$0.01 MS$4.79 M๐Ÿ‡บ๐Ÿ‡ธ USA